HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intestinal metaplasia in benign and malignant gastric lesions.

Abstract
The purpose of this study has been to determine the prevalence of intestinal metaplasia (IM) and its subtypes in normal, benign and malignant states, with special reference to the significance of presence as well as location of sulphomucins in the metaplastic epithelium. Sixty-seven specimens of the normal, benign chronic gastric disease and gastric carcinoma have been studied. The overall prevalence of IM in gastric carcinoma has been found to be much higher (67 percent) than in the normal (nil) and benign lesions of stomach (11 percent). The sulphomucins producing IM also has a higher prevalence in gastric carcinoma (70 percent) but can occur in benign conditions also (40 percent). On the other hand Type III IM, characterized by sulphomucins in the columnar cells is seen only in gastric carcinoma, and not in the benign lesions.
AuthorsU Kini, V Nirmala, J A Thomas
JournalIndian journal of pathology & microbiology (Indian J Pathol Microbiol) Vol. 33 Issue 2 Pg. 137-43 (Apr 1990) ISSN: 0377-4929 [Print] India
PMID2391144 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Carcinoma (pathology)
  • Gastric Mucosa (pathology)
  • Humans
  • Intestinal Mucosa (pathology)
  • Metaplasia
  • Stomach Diseases (pathology)
  • Stomach Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: